Lotje Anna Hoogervorst

Lotje Anna Hoogervorst

Auto-generated profile, based on publicly available information

Lotje Anna Hoogervorst

Department of Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2023 in International Journal of Health Policy and Management
Verified
Journal Article
Open access
PDF file
LHLotje A. Hoogervorst
Lotje A. Hoogervorst
TGTimon H. Geurkink
Timon H. Geurkink
ALAnne Lübbeke
Anne Lübbeke
SBSergio Buccheri
Sergio Buccheri
JSJan Schoones
Jan Schoones
PMPerla J. Marang-Van de Mheen
Perla J. Marang-Van de Mheen
Background: The European Union Medical Device Regulation (MDR) requires manufacturers to undertake post-market clinical follow-up (PMCF) to assess the safety and performance of their devices following approval and Conformité Européenne (CE) marking. The quality and reliability of device registries for this Regulation have not been reported. As part of the Coordinating Research and Evidence for Medical Devices (CORE-MD) project, we identified and reviewed European cardiovascular and orthopaedic registries to assess their structures, methods, and suitability as data sources for regulatory purposes. Methods: Regional, national and multi-country European cardiovascular (coronary stents and valve repair/replacement) and orthopaedic (hip/knee prostheses) registries were identified using a systematic literature search. Annual reports, peer-reviewed publications, and websites were reviewed to extract publicly available information for 33 items related to structure and methodology in six domains and also for reported outcomes. Results: Of the 20 cardiovascular and 26 orthopaedic registries fulfilling eligibility criteria, a median of 33% (IQR: 14%-71%) items for cardiovascular and 60% (IQR: 28%-100%) items for orthopaedic registries were reported, with large variation across domains. For instance, no cardiovascular and 16 (62%) orthopaedic registries reported patient/ procedure-level completeness. No cardiovascular and 5 (19%) orthopaedic registries reported outlier performances of devices, but each with a different outlier definition. There was large heterogeneity in reporting on items, outcomes, definitions of outcomes, and follow-up durations. Conclusion: European cardiovascular and orthopaedic device registries could improve their potential as data sources for regulatory purposes by reaching consensus on standardised reporting of structural and methodological characteristics to judge the quality of the evidence as well as outcomes.

28 April 2022 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
Hidde M KroonHidde M Kroon
Hidde M Kroon
LHLotje A. Hoogervorst
Lotje A. Hoogervorst
NHNicole Hanna-Rivero
Nicole Hanna-Rivero
LTLuke Traeger
Luke Traeger
NDNagendra N. Dudi-Venkata
Nagendra N. Dudi-Venkata
TSTarik Sammour
Tarik Sammour

24 January 2025 in Acta Orthopaedica
Verified
Journal Article
Open access
PDF file
ALAnne Lübbeke
Anne Lübbeke
LHLotje A Hoogervorst
Lotje A Hoogervorst
PMPerla J Marang-Van de Mheen
Perla J Marang-Van de Mheen
HPHeather Prentice
Heather Prentice
MPMartin Paulsson
Martin Paulsson
TGthe ISAR group
the ISAR group
Background and purpose: The amount of information publicly available from arthroplasty registries is large but could be used more effectively. This project aims to improve the knowledge concerning existing registries to facilitate access, transparency, harmonization, and reporting.Methods: Within the International Society of Arthroplasty Registries (ISAR) we aimed at developing, testing, adopting, and making publicly available a short, standardized registry description with items considered relevant for stakeholders using a cross-sectional study survey. Items were chosen based on a literature review and expert advice, selected by 9 ISAR working group members, tested iteratively in 3 registries, and commented upon by 4 external experts. All 29 ISAR member registries as of July 2023 were invited to participate in the project.Results: Included items covered general descriptive information regarding registries, information related to governance, outcomes, data quality, data access, and registry production. The template was adopted, completed, and made publicly available by 25 of the 29 registries. Of those, 2/3 were national registries. 23 captured both hip and knee arthroplasties and 10 captured shoulder arthroplasties. Most registries had public reporting of data quality, methods, and results. Data was accessible in all but 2 registries, mainly as aggregated data. Important items relevant to registry quality for researchers to consistently indicate in scientific papers include scope, inclusion criteria, outcomes definitions, coverage/completeness, and validation processes.Conclusion: This ISAR initiative implemented a short, standardized description to facilitate appropriate use of orthopedic registry data worldwide relevant for a diverse group of stakeholders including researchers, industry, public health and regulatory agencies.

1 April 2021 in The Bone & Joint Journal
Verified
Journal Article
Closed access
LHLotje A. Hoogervorst
Lotje A. Hoogervorst
MHMelissa J. Hart
Melissa J. Hart
PSPamela M. Simpson
Pamela M. Simpson
LKLara A. Kimmel
Lara A. Kimmel
AOAndrew Oppy
Andrew Oppy
BGBelinda J. Gabbe
Belinda J. Gabbe
Aims: Complex fractures of the femur and tibia with associated severe soft tissue injury are often devastating for the individual. The aim of this study was to describe the two-year patient-reported outcomes of patients in a civilian population who sustained a complex fracture of the femur or tibia with a Mangled Extremity Severity Score (MESS) of ≥ 7, whereby the score ranges from 2 (lowest severity) to 11 (highest severity).Methods: Patients aged ≥ 16 years with a fractured femur or tibia and a MESS of ≥ 7 were extracted from the Victorian Orthopaedic Trauma Outcomes Registry (January 2007 to December 2018). Cases were grouped into surgical amputation or limb salvage. Descriptive analysis were used to examine return to work rates, three-level EuroQol five-dimension questionnaire (EQ-5D-3L), and Glasgow Outcome Scale-Extended (GOS-E) outcomes at 12 and 24 months post-injury.Results: In all, 111 patients were included: 90 (81%) patients who underwent salvage and 21 (19%) patients with surgical amputation. The mean age of patients was 45.8 years (SD 15.8), 93 (84%) were male, 37 (33%) were involved in motor vehicle collisions, and the mean MESS score was 8.2 (SD 1.4). Two-year outcomes in the cohort were poor: six (7%) patients achieved a GOS-E good recovery, the mean EQ-5D-3L summary score was 0.52 (SD 0.27), and 17 (20%) patients had returned to work.Conclusion: A small proportion of patients with severe lower limb injury (MESS ≥ 7) achieved a good level of function 24 months post-injury. Further follow-up is needed to better understand the long-term trajectory of these patients, including delayed amputation, hospital readmissions, and healthcare utilization. Cite this article: Bone Joint J 2021;103-B(4):769–774.

18 March 2024 in Osteoarthritis and Cartilage Open
Verified
Journal Article
Open access
STSietse E.S. Terpstra
Sietse E.S. Terpstra
LHLotje A. Hoogervorst
Lotje A. Hoogervorst
JVJeroen H.P.M. van der Velde
Jeroen H.P.M. van der Velde
RMRenée de Mutsert
Renée de Mutsert
LSLotte A. van de Stadt
Lotte A. van de Stadt
MKMargreet Kloppenburg
Margreet Kloppenburg
To investigate the construct validity of the SQUASH (Short QUestionnaire to ASsess Health-enhancing physical activity). This is a cross-sectional analysis using baseline measurements from middle-aged participants in the Netherlands Epidemiology of Obesity (NEO) study. The SQUASH consists of questions on eleven physical activities investigating days per week, average duration per day and intensity, leading to a summed score in Metabolic Equivalent of Task hours (MET h) per week. To assess convergent validity, a Spearman's rank correlation between SQUASH and ActiHeart was calculated. To assess extreme group validity, three groups expected to differ in SQUASH total physical activity outcome were compared. For discriminative validity, a Spearman's rank correlation between SQUASH physical activity and participant height was investigated. SQUASH data were available for 6550 participants (mean age 56 years, 44% men, mean BMI 26.3, 15% with knee OA, 13% with hand OA). Median physical activity (interquartile range) was 118 (76; 154) MET h/week according to SQUASH and 75 (58; 99) according to ActiHeart. Convergent validity was weak (rho ​= ​0.20). For all three extreme group comparisons, a statistically significant difference was present. Discriminative validity was present (rho ​= ​0.01). Compared with the reference quintile, those with a discrepancy SQUASH ​> ​ActiHeart and SQUASH ​< ​ActiHeart were relatively younger and more often male. The construct validity of the SQUASH seems sub-optimal. Physical activity reported by the SQUASH was generally higher than reported by ActiHeart. Whether the differences between SQUASH and ActiHeart are e.g. due to different underlying domains, limitations to our study, or reflect true differences needs further investigation.

20 July 2023 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
PDF file
EBElyne M. Brunink
Elyne M. Brunink
LHLotje A. Hoogervorst
Lotje A. Hoogervorst
KSKoen Steentjes
Koen Steentjes
DBDemien Broekhuis
Demien Broekhuis
MBMark G. J. de Boer
Mark G. J. de Boer
Hematogenous osteomyelitis caused by Streptococcus intermedius is rare, particularly in immunocompetent adults. The aim of this paper is to provide an overview of the clinical presentation, prognosis as well as treatment of this disease, with the focus on immunocompetent adults. Six medical literature libraries were searched to identify studies reporting on Streptococcus intermedius induced hematogenous osteomyelitis in immunocompetent adults. In addition, we presented a case of a 44-year-old man from our institution that is illustrative for this disease. Four case reports describing four patients were identified by this systematic literature review. Hence, the data of five patients (including our case) were assessed. The most common presenting symptom was localised pain, followed by fever. Portal entries were found in two patients (general periodontitis and necrotic dentition). The localisations of osteomyelitis were diverse: femoral (two patients), lumbar spine (two patients), and the iliac bone (one patient). Treatment strategies varied strongly, but antibiotics (penicillins) were administered in each case, and two patients underwent surgical debridement. Follow-up ranged from 2 weeks to more than 6 months; one patient died from septic shock. Only a very limited number of immunocompetent adults with Streptococcus intermedius induced hematogenous osteomyelitis have been described. Based on the available data, we summarised the clinical presentation, prognosis as well as treatment of hematogenous osteomyelitis caused by Streptococcus intermedius in this patient population.